REPLACE-2 Finds Bivalirudin A Substitute For Standard PCI Anticoagulants
This article was originally published in The Gray Sheet
Executive Summary
Bivalirudin may be an acceptable alternative to heparin in anticoagulation therapy during percutaneous coronary interventions, REPLACE-2 study investigators suggest